key: cord-0963823-ln2r3onj
authors: Shestakova, Tatyana S.; Deev, Sergey L.; Khalymbadzha, Igor А.; Rusinov, Vladimir L.; Paramonov, Alexander S.; Arseniev, Alexander S.; Shenkarev, Zakhar O.; Charushin, Valery N.; Chupakhin, Oleg N.
title: Antiviral drug Triazavirin, selectively labeled with (2)H, (13)C, and (15)N stable isotopes. Synthesis and properties
date: 2021-05-12
journal: Chem Heterocycl Compd (N Y)
DOI: 10.1007/s10593-021-02927-1
sha: f81ea2a232ba58a7ab6c6dc678ec53f70228042a
doc_id: 963823
cord_uid: ln2r3onj

[Image: see text] Isotope-labeled antiviral drug Triazavirin containing (2)H, (13)C, and (15)N atoms in its structure has been synthesized. (13)C(2)H(3)I and KS(13)CN served as donors of (13)C isotopes. The use of (13)С-MeI containing (2)H atoms made it possible to additionally incorporate deuterium labels into the structure of the compound. The (15)N atoms were incorporated using (15)N-enriched sodium nitrite, aminoguanidine carbonate, and ethyl nitroacetate. The resulting (2)H(3),(13)C(2),(15)N(3)-Triazavirin was characterized by NMR spectroscopy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10593-021-02927-1.

Triazavirin (TZV) (1) is used to treat diseases caused by various types of influenza A and B viruses, including the pandemic H5N1 (avian influenza virus). [1] [2] [3] [4] [5] [6] Research to expand the spectrum of action of this drug is ongoing. The data obtained make it possible to classify TZV as a firstline drug in the treatment of tick-borne viral encephalitis. 7 In addition, TZV (1) is undergoing clinical trials as an antiviral agent against the pandemic strain of coronavirus COVID-19. [8] [9] [10] To evaluate the new data obtained on the activity of TZV, more complete information on the mechanism of its action, bioavailability, and biological transformation would be required. To solve these problems, it is advisable to use compounds enriched in stable isotopes ( 2 H, 13 C, and 15 N) which can be used as internal standards for chromato-mass spectrometry. 11, 12 This strategy makes it possible to investigate blood, serum, and other biological fluids for the presence of the studied biologically active compounds and their metabolites. The ability to analyze the concentrations of a compound and its metabolites is necessary for pharmacokinetic studies and in the selection of effective doses of drugs.

Previously, we proposed the synthesis of labeled TZV ( 2 H 3 , 15 N 3 )-1 containing 2 H and 15 N atoms in its structure (Scheme 1, labeled atoms are indicated in bold). The incorporation of stable isotopes was based on the reaction of the diazonium salt ( 2 H, 15 N 2 )-2 with ethyl nitroacetate ( 15 N)-3. 13 It is important to note that this compound was used as an internal standard in studying the effect of TZV (1) on the aggregation of natural peptides prone to selfassociation, as exemplified by the β-amyloid peptide (βAP) fragment accumulating in the brains of patients with Alzheimer's disease, and the cytolytic peptide of bee venom melittin. 14 This work presents the preparation of labeled TZV ( 2 H 3 , 13 C 2 , 15 N 3 )-1 containing two additional 13 C atoms (Scheme 2). In this case, the inclusion of 13 C isotopes in the structures of biologically active compounds makes it possible to additionally involve the method of 13 C NMR spectroscopy for the study of metabolic and pharmacokinetic pathways. 15, 16 Enriched potassium thiocyanate and ( 2 H 3 , 13 C)-MeI were used as donors of 13 Studying compound ( 2 H 3 , 13 C 2 , 15 N 3 )-1 by NMR spectroscopy it was found that in the 13 C NMR spectrum the signals of all carbon atoms have additional splitting characterized by the constants of the spin-spin interaction 13 С-15 N (J C-N ) with labeled 15 N atoms. The quantitative measurement of J C-N was carried out on the basis of a set of one-dimensional 13 Table 1 . The presence of spin-spin interactions between the 13 С-2 and 13 С-2' atoms with the 15 N-1 atom was additionally confirmed by the data of the 13 С-15 N HMBC two-dimensional spectrum in which the corresponding cross peaks are present (Fig. 1) . Analysis of the 13 С-15 N HMBC two-dimensional spectrum also showed the presence of a long-range constant ( 4 J C-N ) which is due to the interaction between 13 С-2 and 15 N-5 atoms. In addition, a set of cross peaks with the corresponding J C-N constants between the C-3a, C-6, and C-7 atoms with a natural content of the 13 C isotope and 15 N-enriched N-1, N-5, and N-6' atoms was observed in the 13 С-15 N HMBC spectrum.

Analysis of the 13 С-15 N HMBC spectrum also indicated the possible signal frequencies of the N-3, N-4, and N-8 atoms with the natural abundance of the 15 N isotope (Fig. 1 , Table 1 ). Using the one-dimensional 13 C NMR spectrum acquired with decoupling from 2 H and 15 N atoms, the geminal coupling constant 13 С-13 С ( 2 J C-С ) between the labeled 13 С-2 and 13 С-2' atoms was recorded (Table 1) . At the same time, the recording of the one-dimensional 13 C NMR spectrum with decoupling only from 15 N atoms made it possible to estimate the 2 H-13 C ( 1 J C-D ) heteronuclear interaction. The presence of the 1 J C-D constant in the signal of the C-2' atom (Table 1) unambiguously proves the presence of deuterium atoms in Fig. 1 ) presented as a doublet of doublets at 259.1 ppm (N-1) and two doublets at 397.0 and 367.9 ppm (N-5 and N-6', respectively). The assignment of signals in the one-dimensional 15 N NMR spectrum was carried out on the basis of measuring the 13 С-15 N coupling constant and analysis of chemical shifts. 13 The 15 N-15 N spin-spin interaction is reflected in the structure of the signals of the N-5 and N-6' atoms. The multiplicity of the resonance signal of the 15 N-1 atom is explained by the presence of two 13 C-15 N coupling constants with labeled carbon atoms. This conclusion was confirmed by acquiring one-dimensional 15 N NMR spectra recorded with selective decoupling from the 13 C-2 and 13 C-2' atoms ( Fig. S2 , Supplementary information file). These experiments made it possible to quantitatively measure the direct constant 1 J C2-N1 (Table 1) .

To conclude, we have developed methods that allow, in addition to the 2 H and 15 N atoms, to selectively incorporate 13 C isotopes into the structure of the antiviral drug Triazavirin. As a result, a sample was obtained containing three types of stable isotopes at once which was characterized by NMR spectroscopy. The practical use of labeled Triazavirin can significantly expand the possibilities in a comprehensive study of the bioavailabi-lity, pharmacokinetics, and metabolic pathways of this antiviral drug using mass spectrometry and NMR spectroscopy. This, in turn, can contribute to a more rational choice of treatment strategies. Experimental 1 Н, 13 C, and 15 N NMR (700, 175, and 71 MHz, respectively) and 13 C-15 N HMBC spectra of compound ( 2 H 3 , 13 C 2 , 15 N 3 )-1 were acquired on a Bruker Avance 700 spectrometer equipped with a triple resonance sensor ( 1 H, 13 C, 15 N) in DMSO-d 6 , using residual solvent signals (2.50 ppm for 1 Н nuclei) or solvent signals (40.11 ppm for 13 С nuclei) as internal standard; liquid NН 3 (for 15 N nuclei) was used as external standard. For measuring 13 С-13 С and 13 С-15 N SSCCs, a previously developed method 17 of nonlinear approximation of line shapes in one-dimensional 13 C NMR spectra recorded with and without decoupling from 2 H and 15 N nuclei was used. For selective decoupling of 15 N nuclei, adiabatic pulses (WURST-20) with a length of 10-20 ms and an inversion range of ~ 1 kHz (14 ppm) for 15 N nuclei were used. The decoupling of the 2 H nuclei was carried out by the WALTZ-16 wideband sequence. The 13 C-15 N HMBC two-dimensional spectra were recorded using delays for the transfer of magnetization between the 13 C and 15 N nuclei in the range of 50-100 ms. In some cases, selective decoupling of the 15 N-1 nucleus was achieved using saturation of the corresponding 15 N frequency during magnetization transfer and 13 C detection. 1 Н, 13 C, and 15 N NMR spectra for compounds ( 13 C, 15 N)-5 and ( 2 H 3 , 13 C, 15 N)-6 were registered on a Bruker Avance II spectrometer (400, 100, and 41 MHz, respectively), DMSO-d 6 solvent. TMS was used as internal standard (for 13 С, 1 Н nuclei), liquid ammonia was used as the external standard (for 15 N nuclei). High-resolution mass spectra were recorded on a Finnigan LTQ FT mass spectrometer equipped with a 7 Tesla superconducting magnet and an Ion Max electrospray ionizer. Melting points were determined in open capillaries on a Stuart SMP3 apparatus.

Ethyl nitroacetate ( 15 N)-3 13 ( 15 N enrichment 98%) and aminoguanidine ( 15 N)-4 18 ( 15 N enrichment 98%) were synthesized according to the previously described methods. Labeled MeI ( 2 H, 99.5% and 13 С, 99%) was supplied by Aldrich. Enriched with stable isotopes sodium nitrate ( 15 N, 98%) and potassium thiocyanate ( 13 С, 95-98%) were supplied by Cambridge Isotope Laboratories. 2 H 3 , 13 C, 15 N)-6) . Labeled 5-amino-3-mercapto-1,2,4triazole ( 13 C, 15 N)-5 (0.118 g, 1.00 mmol) was added to a solution of KOH (0.062 g, 1.10 mmol) in H 2 O (2.00 ml). The solution was then cooled to 0°С, 13 C 2 H 3 I ( 2 H 99.5%, 13 C 99%; 0.160 g, 1.10 mmol) was added, and the mixture was stirred for 6 h. After evaporation of H 2 O under reduced pressure at a temperature not exceeding 60°C to about half of the initial volume, the formed precipitate was filtered off, washed with ice-cold H 2 O, and dried. The obtained 5-amino-3-methylmercapto-1,2,4-triazole ( 2 H 3 , 13 C, 15 N)-6 (0.082 g, 61%, 2 H 99.5%, 13 C 99%, 15 N 98%) was used in further syntheses without purification. 1 H NMR spectrum, δ, ppm: 5.94 (2H, br. s, NH 2 ); 11.88 (1H, br. s, NH). 13 C NMR spectrum, δ, ppm (J, Hz): 13.0 (sept, 1 J C-D = 21.4, C 2 H 3 ); 156.3 (CS); 157.9 (CNH 2 ). The SSCC for 13 С-15 N was not observed due to signal broadening. 15 15 N 3 )-1). Labeled 5-amino-3-methylmercapto-1,2,4-triazole ( 2 H 3 , 13 С 2 , 15 N)-6 (0.2 g, 1.47 mmol) was added to a mixture of H 2 O (2.00 ml) and concentrated HCl (0.25 ml). The resulting mixture was cooled to -5°С, and a solution of Na 15 NO 2 (0.111 g, 1.50 mmol) in H 2 O (1.00 ml) was added dropwise. The reaction mixture was stirred for 10 min and added to a cooled (0°С) solution of ethyl 15 N-nitroacetate (( 15 N)-3) (0.30 ml) in 17% aqueous Na 2 CO 3 (4.00 ml). The reaction mixture was stirred for 2 h at room temperature, the formed precipitate was filtered and recrystallized from 50% AcOH. Yield 0.185 g (43%, 2 H 99%, 13 

Eksperimental'naya i klinicheskaya farmokologiya